{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T09:49:52.681984+00:00","published_at":"2026-10-19T04:46:31.170154+00:00","section":"board","data":{"state":"PUBLISHED","size":{"value":8,"assertion_class":"alpha_calculated_metric","basis":"Count of published current board seats in this Record. Roster completeness is not asserted.","input_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"]},"chair":null,"lead_independent_director":null,"ceo_chair_combined":null,"independence":{"value":{"independent_directors":4,"directors_with_determination":8,"published_directors":8,"independent_share":0.5},"assertion_class":"alpha_calculated_metric","basis":"Board independence determinations are source facts; the share is computed only over directors with a published determination.","input_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"]},"average_tenure_years":{"value":{"years":3.3,"directors_with_start_date":8},"assertion_class":"alpha_calculated_metric","basis":"Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.","input_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"]},"committee_load":{"value":{"average_memberships":1.67,"directors_with_memberships":3},"assertion_class":"alpha_calculated_metric","basis":"Average published committee memberships per current director with at least one published membership.","input_claim_ids":["alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12"]},"skills_coverage":null,"directors":[{"person":{"alpha_id":"alpha:person:david-m-epstein-ph-d","name":"David M. Epstein, Ph.D.","canonical_url":"https://registry.alpha.ac/people/david-m-epstein-ph-d"},"current_role":"Director","director_since":"2024-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2024-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:gordon-carmichael-ph-d","name":"Gordon Carmichael, Ph.D.","canonical_url":"https://registry.alpha.ac/people/gordon-carmichael-ph-d"},"current_role":"Director","director_since":"2023-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2023-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:han-ying-ph-d","name":"Han Ying, Ph.D.","canonical_url":"https://registry.alpha.ac/people/han-ying-ph-d"},"current_role":"Director","director_since":"2023-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2023-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:ping-zhang","name":"Ping Zhang","canonical_url":"https://registry.alpha.ac/people/ping-zhang"},"current_role":"Director","director_since":"2025-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2025-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:ping-zhang","name":"Ping Zhang","canonical_url":"https://registry.alpha.ac/people/ping-zhang"},"committee_id":"alpha:committee:gyre-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":"2025-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:20","evidence_ids":["alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:renate-parry-ph-d","name":"Renate Parry, Ph.D.","canonical_url":"https://registry.alpha.ac/people/renate-parry-ph-d"},"current_role":"Director","director_since":"2023-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2023-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:rodney-nussbaum","name":"Rodney Nussbaum","canonical_url":"https://registry.alpha.ac/people/rodney-nussbaum"},"current_role":"Director","director_since":"2024-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2024-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:rodney-nussbaum","name":"Rodney Nussbaum","canonical_url":"https://registry.alpha.ac/people/rodney-nussbaum"},"committee_id":"alpha:committee:gyre-therapeutics-inc:audit","committee_name":"Audit","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:18","evidence_ids":["alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:rodney-nussbaum","name":"Rodney Nussbaum","canonical_url":"https://registry.alpha.ac/people/rodney-nussbaum"},"committee_id":"alpha:committee:gyre-therapeutics-inc:audit-chair","committee_name":"Audit · Chair","role":"member","valid_from":"2024-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Audit"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:songjiang-ma","name":"Songjiang Ma","canonical_url":"https://registry.alpha.ac/people/songjiang-ma"},"current_role":"Director","director_since":"2023-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2023-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:thomas-eastling","name":"Thomas Eastling","canonical_url":"https://registry.alpha.ac/people/thomas-eastling"},"current_role":"Director","director_since":"2023-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2023-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:thomas-eastling","name":"Thomas Eastling","canonical_url":"https://registry.alpha.ac/people/thomas-eastling"},"committee_id":"alpha:committee:gyre-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:20","evidence_ids":["alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:thomas-eastling","name":"Thomas Eastling","canonical_url":"https://registry.alpha.ac/people/thomas-eastling"},"committee_id":"alpha:committee:gyre-therapeutics-inc:nominating-and-governance-chair","committee_name":"Nominating and Governance · Chair","role":"member","valid_from":"2023-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Nominating and Governance"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523"],"assertion_class":"source_fact","verification_state":"source_reported"}],"fields_not_published":["chair","lead_independent_director","board_type","median_tenure","average_age","refreshment_rate","gender_diversity","geographic_diversity","succession_risk","overboarding","board_interlocks","attendance"]},"claims":[{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:5","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-m-epstein-ph-d","object_label":"David M. Epstein, Ph.D.","object_source_name_forms":[],"value":"David M. Epstein, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-m-epstein-ph-d","name":"David M. Epstein, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:6","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gordon-carmichael-ph-d","object_label":"Gordon Carmichael, Ph.D.","object_source_name_forms":[],"value":"Gordon Carmichael, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gordon-carmichael-ph-d","name":"Gordon Carmichael, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:7","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:han-ying-ph-d","object_label":"Han Ying, Ph.D.","object_source_name_forms":[],"value":"Han Ying, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:han-ying-ph-d","name":"Han Ying, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:8","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ping-zhang","object_label":"Ping Zhang","object_source_name_forms":[],"value":"Ping Zhang: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ping-zhang","name":"Ping Zhang"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:9","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:renate-parry-ph-d","object_label":"Renate Parry, Ph.D.","object_source_name_forms":[],"value":"Renate Parry, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:renate-parry-ph-d","name":"Renate Parry, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:10","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:rodney-nussbaum","object_label":"Rodney Nussbaum","object_source_name_forms":[],"value":"Rodney Nussbaum: Director, Audit · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:rodney-nussbaum","name":"Rodney Nussbaum"},"title":"Director","role_category":"director","committee":"Audit · Chair","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:11","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:songjiang-ma","object_label":"Songjiang Ma","object_source_name_forms":[],"value":"Songjiang Ma: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:songjiang-ma","name":"Songjiang Ma"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:leadership_role:12","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:thomas-eastling","object_label":"Thomas Eastling","object_source_name_forms":[],"value":"Thomas Eastling: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:thomas-eastling","name":"Thomas Eastling"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-21","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:18","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Rodney Nussbaum; Members Rodney Nussbaum (Chair)","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Rodney Nussbaum","members":[{"display_name":"Rodney Nussbaum","person_slug":"rodney-nussbaum","is_chair":true}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:07e067a8-43a3-4e49-a390-254524565636:committee_record:20","subject_id":"alpha:company:07e067a8-43a3-4e49-a390-254524565636","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Thomas Eastling; Members Thomas Eastling (Chair); Ping Zhang","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Thomas Eastling","members":[{"display_name":"Thomas Eastling","person_slug":"thomas-eastling","is_chair":true},{"display_name":"Ping Zhang","person_slug":"ping-zhang","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T04:46:31.170154+00:00","sources":[{"id":"alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:2c7e2e1f23e140f689a979521c8e4448116c2d8d4ec22dbaca22a68f99bf0523","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"GYRE THERAPEUTICS, INC. DEF 14A 2025-04-21","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":"2025-04-21","retrieved_at":"2026-04-28T23:52:00.625+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:1d7bbbcc2acaf2ee9bd6596dd96ebdf8d1cdce7ea78f8eb8dbd38117a04a833b","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1124105/000114036125014779/ny20044429x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.848,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.882,"cross_source_agreement":0.75,"temporal_completeness":0.813},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":13,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-19T04:46:31.170154+00:00","observed_at":"2026-10-19T04:46:31.170154+00:00","reviewed_at":"2026-10-19T04:46:31.170154+00:00","verified_at":"2026-10-19T04:46:31.170154+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/gyre-therapeutics-inc/board","section":"board","href":"https://registry.alpha.ac/api/public/companies/gyre-therapeutics-inc?format=record&section=board","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}